Elbit Imaging Ltd – ‘20-F’ for 12/31/04 – EX-12.1

On:  Thursday, 6/30/05, at 5:32pm ET   ·   For:  12/31/04   ·   Accession #:  950123-5-8058   ·   File #:  0-28996   ·   Correction:  This Filing’s “Filed as of” Date was Corrected and “Changed as of” 8/10/05 by the SEC on 8/10/05. ®

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Annual Report of a Foreign Private Issuer   —   Form 20-F
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 20-F        Annual Report of a Foreign Private Issuer            233   1.37M 
 2: EX-4.13     Ex-4.13: Framework Transaction Agreement              84    368K 
 3: EX-4.14     Ex-4.14: Transaction Agreement                        63    255K 
 4: EX-10.1     Ex-10.1: Consent of Brightman Almagor & Co.            1      7K 
 5: EX-10.2     Consent of Kpmg Hungaria Kft.                          1      7K 
 6: EX-10.3     Ex-10.3: Consent of Kost, Forer Gabbay & Kasierer      1      6K 
 7: EX-12.1     Ex-12.1: Certificate                                   2±     9K 
 8: EX-13.1     Ex-13.1: Certificate                                   1      7K 

EX-12.1   —   Ex-12.1: Certificate

EX-12.1
TOC
↑Top
Previous
Next
↓Bottom
Just 1st
 
EXHIBIT 12.1

SECTION 302 CERTIFICATION BY PRINCIPAL EXECUTIVE OFFICER AND
PRINCIPAL FINANCIAL OFFICER 

I, Shimon Yitzhaki, certify that:                                     

1.  I have reviewed this annual report on Form 20-F of Elbit Medical  
Imaging Ltd. (the "Company");                                 

2.  Based on my knowledge, this report does not contain any untrue    
         statement of a material fact or omit to state a material fact necessary
        to make the statements made, in light of the circumstances under which
      such statements were made, not misleading with respect to the period
covered by this report;                                       

  3.  Based on my knowledge, the financial statements, and other financial
     information included in this report, fairly present in all material
        respects the financial condition, results of operations and cash flows
      of the Company as of, and for, the periods presented in this report;

   4.  I am responsible for establishing and maintaining disclosure controls
 and procedures (as defined in Exchange Act Rules 13a- 15(e) and
         15d-15(e)) and internal control over financial reporting (as defined in
        Exchange Act Rules 13a- 15(f) and 15d-15(f)) for the Company and have:

      (a)      designed such disclosure controls and procedures, or caused
                such disclosure controls and procedures to be designed under
                 our supervision, to ensure that material information relating
               to the Company, including its consolidated subsidiaries, is
                  made known to us by others within those entities, particularly
          during the period in which this annual report is being
prepared;                                   

(b)      (Reserved)                                           

  (c)      evaluated the effectiveness of the Company's disclosure
            controls and procedures and presented in this report our
                  conclusions about the effectiveness of the disclosure controls
              and procedures as of the end of the period covered by this
report based on such evaluation; and        

        (d)      disclosed in this report any change in the Company's internal
             control over financial reporting that occurred during the
           period covered by the annual report that has materially
               affected, or is reasonably likely to materially affect, the
            Company's internal control over financial reporting; and

5.  I have disclosed, based on my most recent evaluation of internal  
     control over financial reporting, to the Company's auditors and the
        audit committee of Company's board of directors (or persons performing
the equivalent functions):                                    

      (a)      all significant deficiencies and material weaknesses in the
          design or operation of internal control over financial
                 reporting which are reasonably likely to adversely affect the
              Company's ability to record, process, summarize and report
financial information; and                  

       (b)      any fraud, whether or not material, that involves management
         or other employees who have a significant role in the
        Company's internal control over financial reporting.

Date:  June 30, 2005                                                            

/s/ Shimon Yitzhaki                                           
---------------------------                                   
Shimon Yitzhaki                                               
Principal Executive Officer & Principal Financial Officer     

Dates Referenced Herein

This ‘20-F’ Filing		Date		Other Filings
Changed as of / Corrected on:		8/10/05		None on these Dates
Filed on:		6/30/05
For Period End:		12/31/04
				List all Filings